Ocugen Inc

NASDAQ:OCGN 4:00:00 PM EDT

1.18

0.00 (0.00%)

4:11:45 PM EDT: $1.17 -0.01 (-0.85%)

Ocugen Inc Stock, NASDAQ:OCGN

11 Great Valley Parkway, Suite 160, Malvern, Pennsylvania 19355

United States of America

Phone: +1.484.328.4701

Number of Employees: 65

http://www.ocugen.com

Description

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.